2017
DOI: 10.1111/bph.13702
|View full text |Cite
|
Sign up to set email alerts
|

Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome

Abstract: This review explores the current evidence on benefits and harms of therapeutic interventions in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and makes recommendations. CFS/ME is a complex, multi‐system, chronic medical condition whose pathophysiology remains unknown. No established diagnostic tests exist nor are any FDA‐approved drugs available for treatment. Because of the range of symptoms of CFS/ME, treatment approaches vary widely. Studies undertaken have heterogeneous designs and are limite… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
91
0
4

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 96 publications
(96 citation statements)
references
References 132 publications
(162 reference statements)
1
91
0
4
Order By: Relevance
“…Unfortunately, other highly effective interventions for treating fatigue have yet to be identified. In a recent review evaluating the efficacy of treatments for chronic fatigue syndrome, limited benefits were found for some pharmacological (eg, rintatolimod and rituximab) and nonpharmacological (eg, counseling, behavioral, and rehabilitation programs) approaches. However, the effect sizes associated with these treatments are weak.…”
Section: Discussionmentioning
confidence: 99%
“…Unfortunately, other highly effective interventions for treating fatigue have yet to be identified. In a recent review evaluating the efficacy of treatments for chronic fatigue syndrome, limited benefits were found for some pharmacological (eg, rintatolimod and rituximab) and nonpharmacological (eg, counseling, behavioral, and rehabilitation programs) approaches. However, the effect sizes associated with these treatments are weak.…”
Section: Discussionmentioning
confidence: 99%
“…CFS/ME may also be accompanied by other cardinal symptoms that include orthostatic intolerance, unrefreshing sleep, gastrointestinal discomfort, neuropsychological impairment, anxiety/depression, chronic pain and post-exertional malaise lasting more than 24 h. CFS/ME occurs more often in women than in men and is less common among children and adolescents. Currently, no established diagnostic laboratory tests exist, nor are any FDA-approved drugs available for treatment [1]. …”
Section: Introductionmentioning
confidence: 99%
“…Accordingly, many studies have focused on the development of drugs or therapies with respect to fatigue (24,25). In addition, considering the limitations of available therapies for fatigue in modern medicine, potential alternatives from traditional medicine are worth investing because of their safety, availability, and ease of administration (26).…”
Section: Introductionmentioning
confidence: 99%